Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

PRESIDENT AND CEO

Chief Financial Officer

President and CEO

Chief Medical Officer

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer; and ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations. The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms. ORIC Pharmaceuticals, Inc. has a license and collaboration agreement with Voronoi Inc.; a license agreement with Mirati Therapeutics, Inc.; and clinical development collaboration agreement with Pfizer Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the U...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-06	Premium	sold	Premium	Premium	Premium	PRESIDENT AND CEO
2024-02-07	Premium	sold	Premium	Premium	Premium	PRESIDENT AND CEO
2024-02-06	Premium	sold	Premium	Premium	Premium	PRESIDENT AND CEO
2023-12-15	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-12-15	Premium	sold	Premium	Premium	Premium	President and CEO
2023-12-15	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-12-15	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-12-15	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-12-15	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-07-11	Premium	sold	Premium	Premium	Premium	President and CEO
2023-07-10	Premium	sold	Premium	Premium	Premium	President and CEO
2023-07-05	Premium	sold	Premium	Premium	Premium	President and CEO
2023-06-26	Premium	sold	Premium	Premium	Premium	President and CEO
2022-12-15	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2022-12-15	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2022-12-15	Premium	sold	Premium	Premium	Premium	President and CEO
2022-12-15	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2022-12-15	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2022-12-15	Premium	sold	Premium	Premium	Premium	President and CEO
2022-12-15	Premium	acquired	Premium	Premium	Premium	President and CEO
2022-12-15	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2022-12-15	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2022-05-13	Premium	bought	Premium	Premium	Premium	President and CEO
2022-05-12	Premium	bought	Premium	Premium	Premium	President and CEO
2022-05-11	Premium	bought	Premium	Premium	Premium	President and CEO

ORIC - ORIC Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for ORIC